1. Home
  2. NUVL vs W Comparison

NUVL vs W Comparison

Compare NUVL & W Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$123.60

Market Cap

9.8B

Sector

Health Care

ML Signal

HOLD

Logo Wayfair Inc.

W

Wayfair Inc.

HOLD

Current Price

$95.46

Market Cap

11.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
W
Founded
2017
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.8B
11.7B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
NUVL
W
Price
$123.60
$95.46
Analyst Decision
Strong Buy
Buy
Analyst Count
16
28
Target Price
$134.75
$105.82
AVG Volume (30 Days)
4.2M
3.5M
Earning Date
05-08-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.15
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$7.39
Revenue Next Year
$1,239.49
$6.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$71.14
$53.07
52 Week High
$123.69
$119.98

Technical Indicators

Market Signals
Indicator
NUVL
W
Relative Strength Index (RSI) 66.56 68.92
Support Level $98.56 $94.54
Resistance Level $123.62 $108.31
Average True Range (ATR) 0.21 5.34
MACD -0.05 1.21
Stochastic Oscillator 82.41 94.20

Price Performance

Historical Comparison
NUVL
W

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About W Wayfair Inc.

Wayfair engages in e-commerce in the United States (88% of 2025 sales), Canada, the United Kingdom, and Ireland. It's also embarked on expansion into the brick-and-mortar landscape, with 13 stores (excluding outlets) between the AllModern, Birch Lane, Joss & Main, and Wayfair banners. At the end of 2025, the firm offered more than 40 million products from more than 20,000 suppliers under the brands Wayfair, Joss & Main, AllModern, Birch Lane, and Perigold. Its offerings include furniture, everyday and seasonal decor, decorative accents, housewares, as well as advertising and logistics services. Wayfair was founded in 2002 and began trading publicly in 2014.

Share on Social Networks: